Module

Causes and Management of Drug-Resistant HBV

Source: Practical Strategies for the Management of Patients With Drug-Resistant HBV

Causes and Management of Drug-Resistant HBV

Faculty:
Robert S. Brown, Jr., MD, MPH

CME CREDIT INFORMATION

Release Date: 10/24/06

Expiration Date: 10/23/07

Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss clinical data on resistance to the antiviral drugs currently approved for the treatment of chronic hepatitis B
Review the mutations that are associated with reduced HBV susceptibility to antiviral drugs
Describe strategies for preventing the development of drug-resistant strains of HBV
Explain strategies for treating patients with drug-resistant strains of HBV

Topics covered include:

Introduction
Endpoints and Challenges in Hepatitis B Therapy
Clinical Data in the Management of Hepatitis B
Causes and Prevalence of HBV Resistance
Management Options for Patients With Treatment-Refractory or Drug-Resistant HBV
Clinical Strategies to Prevent Drug-Resistant HBV

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.